Management of platelet-directed pharmacotherapy in patients with atherosclerotic coronary artery disease undergoing elective endoscopic gastrointestinal procedures

American Journal of Gastroenterology

Volumn 104, Issue 12, 2009, Pages 2903-2917

  Becker, Richard C ^a   Scheiman, James ^b   Dauerman, Harold L ^c   Spencer, Frederick ^d   Rao, Sunil ^e   Sabatine, Marc ^f   Johnson, David A ^g   Chan, Frances ^h   Abraham, Neena S ⁱ   Quigley, Eamonn M M ^j  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e DURHAM VA MEDICAL CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g Eastern Virginia School of Medicine   (United States)

^h CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

ⁱ BAYLOR COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY COLLEGE CORK   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; NARCOTIC AGENT; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; BARE METAL STENT; BLEEDING; BLOOD PRESSURE; BRAIN HEMORRHAGE; BREATHING; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; DIGESTIVE SYSTEM INJURY; DRUG ELUTING STENT; DRUG SAFETY; DRUG WITHDRAWAL; ELECTIVE SURGERY; ENDOSCOPIC SURGERY; GASTRODUODENAL ULCER; GASTROINTESTINAL SURGERY; HEART INFARCTION; HUMAN; INTRAOCULAR HEMORRHAGE; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; MEDICAL DECISION MAKING; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NONHUMAN; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK REDUCTION; SIDE EFFECT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SURGICAL RISK; THROMBOSIS; UNSTABLE ANGINA PECTORIS; UPPER GASTROINTESTINAL BLEEDING;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY DISEASE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; GRAFT OCCLUSION, VASCULAR; HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; RISK FACTORS; RISK MANAGEMENT; STENTS; THROMBOLYTIC THERAPY;

EID: 72949118284     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.667     Document Type: Review

References (97)

1. Mehta S, Yusuf S, Peters R et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-533
2. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009;119:480-486
3. Lloyd-Jones DM, Larson MG, Beiser A et al. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92.
4. Ford ES, Ajani UA, Croft JB et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398
5. Bhatt DL, Scheiman J, Abraham NS et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2008;52:1502-1517
6. Antman EM, Hand M, Armstrong PW et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2008;51:210-247
7. Sabatine MS, Cannon CP, Gibson CM et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-1189
8. Chen ZM, Jiang LX, Chen YP et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebocontrolled trial. Lancet 2005;366:1607-1621
9. Anderson JL, Adams CD, Antman EM et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2007;50:e1-157.
10. Yusuf S, Zhao F, Mehta SR et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
11. King SB III, Smith SC Jr., Hirshfeld JW Jr. et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2007 Writing Group to Review New Evidence and Update the 2005 ACC/AHA/SCAI Guideline Update for Percutaneous Coronary Intervention). J Am Coll Cardiol 2008;51:172-209.
12. Fischman DL, Leon MB, Baim DS et al. Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
13. Schomig A, Neumann FJ, Kastrati A et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronaryartery stents. N Engl J Med 1996;334:1084-1089
14. Serruys PW, de Jaegere P, Kiemeneij F et al. Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495
15. Leon MB, Baim DS, Popma JJ et al. Stent Anticoagulation Restenosis Study Investigators. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med 1998;339:1665-1671
16. Bhatt DL, Bertrand ME, Berger PB et al. Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting. J Am Coll Cardiol 2002;39:9-14.
17. Bertrand ME, Rupprecht HJ, Urban P et al. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: the Clopidogrel Aspirin Stent International Cooperative Study (CLASSICS). Circulation 2000;102:624-629
18. Muller C, Buttner HJ, Petersen J et al. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents. Circulation 2000;101:590-593
19. Steinhubl SR, Berger PB, Mann JT III et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002;288:2411-2420
20. Bhatt DL, Fox KA, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717
21. Ma L, Elliott SN, Cirino G et al. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc Natl Acad Sci USA 2001;98:6470-6475
22. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322
23. Chin MW, Yong G, Bulsara MK et al. Predictive and protective factors associated with upper gastrointestinal bleeding after percutaneous coronary intervention: a case-control study. Am J Gastroenterol 2007;102:2411-2416
24. Gilard M, Arnaud B, Cornily JC et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol 2008;51:256-260
25. Ho PM, Maddox TM, Wang L et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937-944
26. O'Donoghue M, Braunwald E, Antman EM et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton pump inhibitor. Lancet 2009;374:989-997
27. Wilson GJ, Nakazawa G, Schwartz RS et al. Comparison of inflammatory response after implantation of sirolimus-and paclitaxel-eluting stents in porcine coronary arteries. Circulation 2009;120:141-9, 1-2.
28. Mauri L, Hsieh WH, Massaro JM et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029
29. van Werkum JW, Heestermans AA, de Korte FIet al. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation 2009;119:828-834
30. Cutlip DE, Baim DS, Ho KK et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103:1967-1971
31. Iakovou I, Schmidt T, Bonizzoni E et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130
32. Aoki J, Lansky AJ, Mehran R et al. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation 2009;119:687-698
33. Mega JL, Close SL, Wiviott SD et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med 2009;360:354-362
34. Sianos G, Papafaklis MI, Daemen J et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 2007;50:573-583
35. Ferrari E, Benhamou M, Cerboni P et al. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-459
36. Collet JP, Montalescot G, Blanchet B et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361-2367
37. Schouten O, van Domburg RT, Bax JJ et al. Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007;49:122-124
38. Wilson SH, Fasseas P, Orford JL et al. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003;42:234-240
39. Kaluza GL, Joseph J, Lee JR et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-1294
40. Grines CL, Bonow RO, Casey DE Jr. et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007;49:734-739
41. Finn AV, Joner M, Nakazawa G et al. Pathological correlates of late drugeluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-2441
42. Eisenstein EL, Anstrom KJ, Kong DF et al. Clopidogrel use and longterm clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159-168
43. Airoldi F, Colombo A, Morici N et al. Incidence and predictors of drugeluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 2007;116:745-754
44. Kimura T, Morimoto T, Nakagawa Y et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009;119:987-995
45. Eisenberg MJ, Richard PR, Libersan D et al. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009;119:1634-1642
46. Santilli F, Rocca B, De Cristofaro R et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance." J Am Coll Cardiol 2009;53:667-677
47. Taggart DP, Siddiqui A, Wheatley DJ. Low-dose preoperative aspirin therapy, postoperative blood loss, and transfusion requirements. Ann Thorac Surg 1990;50:424-428
48. Wallentin L, Becker RC, Budaj A et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057
49. Vicenzi MN, Meislitzer T, Heitzinger B et al. Coronary artery stenting and non-cardiac surgery-a prospective outcome study. Br J Anaesth 2006;96:686-693
50. Broad L, Lee T, Conroy M et al. Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery. Br J Anaesth 2007;98:19-22.
51. Patti G, Colonna G, Pasceri V et al. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2005;111:2099-2106
52. Gurbel PA, Becker RC, Mann KG et al. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 2007;50:1822-1834
53. Price MJ, Berger PB, Angiolillo DJ et al. Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. Am Heart J 2009;157:818-24, 824.e1.
54. Arrowsmith JB, Gerstman BB, Fleischer DE et al. Results from the American Society for Gastrointestinal Endoscopy/U.S. Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc 1991;37:421-427
55. Quine MA, Bell GD, McCloy RF et al. Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut 1995;36:462-467
56. Rogers BH, Silvis SE, Nebel OT et al. Complications of flexible fiberoptic colonoscopy and polypectomy. Gastrointest Endosc 1975;22:73-77
57. Alam M, Schuman BM, Duvernoy WF et al. Continuous electrocardiographic monitoring during colonoscopy. Gastrointest Endosc 1976;22:203-205
58. Fletcher GF, Earnest DL, Shuford WF et al. Electrocardiographic changes during routine sigmoidoscopy. Arch Intern Med 1968;122:483-486
59. Fujita R, Kumura F. Arrythmias and ischemic changes of the heart induced by gastric endoscopic procedures. Am J Gastroenterol 1975;64:44-48
60. Mathew PK, Ona FV, Damevski K et al. Arrhythmias during upper gastrointestinal endoscopy. Angiology 1979;30:834-840
61. Marsh WH, Bronner MH, Yantis PL et al. Ventricular ectopy associated with peroral colonic lavage. Gastrointest Endosc 1986;32:259-263
62. Tezuka K, Nomura M, Saito K et al. Changes in autonomic nervous activity during colonoscopy using spectral analysis of heart rate variability. Dig Endosc 2000;12:155-161 (Pubitemid 30315989)
63. Cappell MS, Abdullah M. Management of gastrointestinal bleeding induced by gastrointestinal endoscopy. Gastroenterol Clin North Am 2000;29:125-167, vi-vii.
64. Veitch AM, Baglin TP, Gershlick AH et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008;57:1322-1329
65. Rabeneck L, Paszat LF, Hilsden RJ et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008;135:1899-906.e1.
66. Watabe H, Yamaji Y, Okamoto M et al. Risk assessment for delayed hemorrhagic complication of colonic polypectomy: polyp-related factors and patient-related factors. Gastrointest Endosc 2006;64:73-78
67. Singaram C, Torbey CF, Jacoby RF. Delayed postpolypectomy bleeding. Am J Gastroenterol 1995;90:146-147
68. Nelson DB, McQuaid KR, Bond JH et al. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002;55:307-314
69. Sorbi D, Norton I, Conio M et al. Postpolypectomy lower GI bleeding: descriptive analysis. Gastrointest Endosc 2000;51:690-696
70. Sawhney MS, Salfiti N, Nelson DB et al. Risk factors for severe delayed postpolypectomy bleeding. Endoscopy 2008;40:115-119
71. Tolliver KA, Rex DK. Colonoscopic polypectomy. Gastroenterol Clin North Am 2008;37:229-251
72. Horiuchi A, Nakayama Y, Tanaka N et al. Prospective randomized trial comparing the direct method using a 24 Fr bumper-button-type device with the pull method for percutaneous endoscopic gastrostomy. Endoscopy 2008;40:722-726
73. Williams EJ, Taylor S, Fairclough P et al. Risk factors for complication following ERCP: results of a large-scale, prospective multicenter study. Endoscopy 2007;39:793-801.
74. ASGE Technology Committee, Kantsevoy SV, Adler DG et al. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc 2008;68:11-18
75. Hui AJ, Wong RMY, Ching JYL et al. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 2004;59:44-48
76. Shiffman ML, Farrel MT, Yee YS. Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDS. Gastrointest Endosc 1994;40:458-462
77. YousfiM, Gostout CJ, Baron TH et al. Postpolypectomy lower gastrointestinal bleeding: potential role of aspirin. Am J Gastroenterol 2004;99:1785-1789
78. Hussain N, Alsulaiman R, Burtin P et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther 2007;25:579-584
79. Hui CK, Lai KC, Yuen MF et al. Does withholding aspirin for one week reduce the risk of post-sphincterotomy bleeding? Aliment Pharmacol Ther 2002;16:929-936
80. Sharis P, Cannon C, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998;129:394-405.
81. Patrono C, Coller B, FitzGerald GA et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(Suppl):234S-64S.
82. Fork FT, Lafolie P, Toth E et al. Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study. Scand J Gastroenterol 2000;35:464-469
83. Ernst A, Eberhardt R, Wahidi M et al. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest 2006;129:734-737
84. Zuckerman MJ, Hirota WK, Adler DG et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005;61:189-194
85. Diener H, Bogousslavsky J, Brass LM. Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebocontrolled trial. Lancet 2004;364:331-337
86. Buresly K, Eisenberg M, Zhang X et al. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 2005;165:784-789
87. Ono S, Fujishiro M, Niimi K et al. Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agents. Dig Liver Dis 2009;41:725-728
88. Uedo N, Takeuchi Y, Yamada T et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol 2007;102:1610-1616
89. Shioji K, Suzuki Y, Kobayashi M et al. Prophylactic clip application does not decrease delayed bleeding after colonoscopic polypectomy. Gastrointest Endosc 2003;57:691-694
90. Friedland S, Soetikno R. Colonoscopy with polypectomy in anticoagulated patients. Gastrointest Endosc 2006;64:98-100.
91. Howell DA, Loew BJ, Sanders MK et al. Use of hemostatic clips in patients undergoing colonoscopy in the setting of coumadin antithrombotic therapy. Gastrointest Endosc 2006;63:AB99.
92. Di Giorgio P, De Luca L, Calcagno G et al. Detachable snare versus epinephrine injection in the prevention of postpolypectomy bleeding: a randomized and controlled study. Endoscopy 2004;36:860-863
93. Iishi H, Tatsuta M, Narahara H et al. Endoscopic resection of large pedunculated colorectal polyps using a detachable snare. Gastrointest Endosc 1996;44:594-597
94. Paspatis GA, Paraskeva K, Theodoropoulou A et al. A prospective, randomized comparison of adrenaline injection in combination with detachable snare versus adrenaline injection alone in the prevention of postpolypectomy bleeding in large colonic polyps. Am J Gastroenterol 2006;101:2805-2809
95. Sung JY, Chung SC, Low JM et al. Systemic absorption of epinephrine after endoscopic submucosal injection in patients with bleeding peptic ulcers. Gastrointest Endosc 1993;39:20-22
96. Sung J, Lau J, Ching J et al. Can aspirin be reintroduced with PPI inhibitor infusion after endoscopic hemostasis: a double-blind randomized controlled trial. Gastroenterology 2008;130:A44.
97. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339